Meta-analysis of human papillomavirus infection concordance

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 11, 2010, Pages 2916-2931

  Reiter, Paul L ^a,b   Pendergraft III, William F ^c   Brewer, Noel T ^a,b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DNA HYBRIDIZATION; HETEROSEXUALITY; HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

FEMALE; HETEROSEXUALITY; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; SEXUAL BEHAVIOR; SEXUAL PARTNERS;

EID: 78549295260     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0576     Document Type: Article

References (64)

1. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006;6:21-31.
2. Gillison ML, Shah KV. Chapter 9: role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;31:57-65.
3. Cates W, Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999;26:S2-7.
4. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis 2002;186:462-9.
5. Giuliano AR, Lu B, Nielson CM, et al. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis 2008;198:827-35.
6. Trottier H, Mahmud S, Prado JC, et al. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 2008;197:1436-47.
7. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999;37:3316-22.
8. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006;24:S3/35-41.
9. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:3036-46.
10. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006;24:S3/11-25.
11. Pfister H. Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;31:52-6.
12. Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009;65:13-8.
13. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
14. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005;23:1107-22.
15. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol 2008;198:500.e1-7.
16. Burchell AN, Richardson H, Mahmud SM, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006;163:534-43.
17. Goodman MT, Shvetsov YB, McDuffie K, et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008;68:8813-24.
18. Munoz N, Mendez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190:2077-87.
19. Syrjanen S, Saastamoinen J, Chang FJ, Ji HX, Syrjanen K. Colposcopy, punch biopsy, in situ DNA hybridization, and the polymerase chain reaction in searching for genital human papillomavirus (HPV) infections in women with normal PAP smears. J Med Virol 1990;31:259-66.
20. Nuovo GJ, Blanco JS, Leipzig S, Smith D. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia. Obstet Gynecol 1990;75:1006-11.
21. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1-24.
22. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:626-9.
23. Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:630-2.
24. Bleeker MC, Hogewoning CJ, Berkhof J, et al. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005;41:612-20.
25. Giovannelli L, Bellavia C, Capra G, et al. HPV group- and type-specific concordance in HPV infected sexual couples. J Med Virol 2007;79:1882-8.
26. Baken LA, Koutsky LA, Kuypers J, et al. Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 1995;171:429-32.
27. Bar-Am A, Niv J. The role of HPV DNA in the evaluation and follow-up of asymptomatic male sexual partners of females with CIN3. Eur J Gynaecol Oncol 2007;28:207-10.
28. Benevolo M, Mottolese M, Marandino F, et al. HPV prevalence among healthy Italian male sexual partners of women with cervical HPV infection. J Med Virol 2008;80:1275-81.
29. Campion MJ, Singer A, Clarkson PK, McCance DJ. Increased risk of cervical neoplasia in consorts of men with penile condylomata acuminata. Lancet 1985;1:943-6.
30. Franceschi S, Castellsague X, Dal Maso L, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002;86:705-11.
31. Gal D, Friedman M, Mitrani-Rosenbaum S. Transmissibility and treatment failures of different types of human papillomavirus. Obstet Gynecol 1989;73:308-11.
32. Giraldo PC, Eleuterio J, Jr., Cavalcante DI, Goncalves AK, Romao JA, Eleuterio RM. The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions. Eur J Obstet Gynecol Reprod Biol 2008;137:88-91.
33. Golijow CD, Perez LO, Smith JS, Abba MC. Human papillomavirus DNA detection and typing in male urine samples from a high-risk population from Argentina. J Virol Methods 2005;124:217-20.
34. Gomousa-Michael M, Deligeorgi-Politi H, Condi-Paphiti A, Rammou-Kinia R, Ghionis J, Belca-Hari K. Human papillomavirus identification and typing of both sexual partners. Acta Cytol 1997;41:244-50.
35. Gross G, Ikenberg H, de Villiers E, Schneider A, Wagner D, Gissmann L. Bowenoid papulosis: a venereally transmissible disease as reservoir for HPV 16. In: Peto R, zur Hausen H, editors. Viral etiology of cervical cancer. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1986, p. 149-65.
36. Gupta A, Arora R, Gupta S, et al. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens. J Clin Virol 2006;37:190-4.
37. Hernandez BY, Wilkens LR, Zhu X, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008;14:888-94.
38. Hillman RJ, Ryait BK, Botcherby M, Taylor-Robinson D. Changes in HPV infection in patients with anogenital warts and their partners. Genitourin Med 1993;69:450-6.
39. Hippelainen MI, Yliskoski M, Syrjanen S, et al. Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis 1994;21:76-82.
40. Ho L, Tay SK, Chan SY, Bernard HU. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis 1993;168:803-9.
41. Inoue M, Nakazawa A, Fujita M, Tanizawa O. Human papillomavirus (HPV) type 16 in semen of partners of women with HPV infection. Lancet 1992;339:1114-5.
42. Konno R, Shikano K, Horiguchi M, et al. Detection of human papillomavirus DNA in genital condylomata in women and their male partners by using in situ hybridization with digoxygenin labeled probes. Tohoku J Exp Med 1990;160:383-90.
43. Kyo S, Inoue M, Koyama M, Fujita M, Tanizawa O, Hakura A. Detection of high-risk human papillomavirus in the cervix and semen of sex partners. J Infect Dis 1994;170:682-5.
44. Monsonego J, Zerat L, Catalan F, Coscas Y. Genital human papillomavirus infections: correlation of cytological, colposcopic and histological features with viral types in women and their male partners. Int J STD AIDS 1993;4:13-20.
45. Nakazawa A, Inoue M, Fujita M, Tanizawa O, Hakura A. Detection of human papillomavirus type 16 in sexual partners of patients having cervical cancer by polymerase chain reaction. Jpn J Cancer Res 1991;82:1187-90.
46. Nicolau SM, Camargo CG, Stavale JN, et al. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005;65:251-5.
47. Nieminen P, Koskimies AI, Paavonen J. Human papillomavirus DNA is not transmitted by semen. Int J STD AIDS 1991;2:207-8.
48. Rintala MA, Grenman SE, Puranen MH, et al. Transmission of highrisk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol 2005;43:376-81.
49. Rosemberg SK, Reid R, Greenberg M, Lorincz AT. Sexually transmitted papillomaviral infection in the male: II. The urethral reservoir. Urology 1988;32:47-9.
50. Rotola A, Costa S, Monini P, et al. Impact of sexual habits on the clinical evaluation of male HPV infection. Eur J Epidemiol 1994;10:373-80.
51. Schneider A, Kirchmayr R, De Villiers EM, Gissmann L. Subclinical human papillomavirus infections in male sexual partners of female carriers. J Urol 1988;140:1431-4.
52. Strand A, Rylander E, Wilander E, Zehbe I. HPV infection in male partners of women with squamous intraepithelial neoplasia and/or high-risk HPV. Acta Derm Venereol 1995;75:312-6.
53. Wickenden C, Hanna N, Taylor-Robinson D, et al. Sexual transmission of human papillomaviruses in heterosexual and male homosexual couples, studied by DNA hybridisation. Genitourin Med 1988;64:34-8.
54. Thompson DL, Douglas JM, Jr., Foster M, et al. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis 2004;190:1563-74.
55. Lu B, Wu Y, Nielson CM, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis 2009;199:362-71.
56. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009;360:1298-309.
57. Giuliano AR, Lazcano E, Villa LL, et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2009;124:1251-7.
58. Giuliano AR, Nielson CM, Flores R, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007;196:1146-52.
59. Flores R, Abalos AT, Nielson CM, Abrahamsen M, Harris RB, Giuliano AR. Reliability of sample collection and laboratory testing for HPV detection in men. J Virol Methods 2008;149:136-43.
60. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006;55:1-94.
61. Hoover K, Friedman A, Montano D, Kasprzyk D, Greek A, Hogben M. What about the partners of women with abnormal pap or positive HPV tests? Sex Transm Dis. In press.
62. Munoz N, Manalastas R, Jr., Pitisuttithum P, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009;373:1949-57.
63. Olsson SE, Kjaer SK, Sigurdsson K, et al. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin 2009;5:696-704.
64. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009;200:1059-67.